Sun Pharma Q1 earnings call set for July 31 after profit surge
pre-market1 source ↓written by the desknot a recommendation
- earnings call
- 31 July 2026
- in Q4
- 34% profit jump
- net profit reaching
- ₹2,654 cr
- 19% YoY
- of total sales
- 6.5%
Sun Pharmaceutical Industries has scheduled its Q1 FY27 earnings call for 31 July 2026. This follows a 34% profit jump in Q4, with net profit reaching ₹2,654 cr. Investors are keen on updates regarding USFDA regulatory status and the specialty drug pipeline.
Key Points:
• Specialty revenue growth of 19% YoY
• R&D spend at 6.5% of total sales
• US revenue contributes 31% of total sales
The focus remains on transitioning from generics to specialty products, now over 16% of global sales.
Not investment advice. For informational purposes only.